GlassScriptPhysician profile
Carl R Doerhoff
NPI 1003800244
$51,836.08
in general payments reported to CMS, 2019-2025
11 companies · $6,866 in 2025
The $6,866 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $8,165 · 2021: $11K · 2022: $10K · 2023: $1,764 · 2024: $124 · 2025: $6,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,750 · Travel and Lodging: $1,310 · Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,750.00 |
| Travel and Lodging | $1,309.86 |
| Food and Beverage | $693.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $48,418.01 | 2019-2025 | Gore Synecor Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Davol INC. | $1,379.40 | 2023 | Phasix Mesh |
| Innocoll Pharmaceuticals Limited | $1,350.00 | 2021 | |
| Becton, Dickinson and Company | $174.83 | 2023 | Phasix Mesh |
| Tela Bio, INC. | $147.17 | 2019-2021 | |
| Asensus Surgical, INC. | $136.33 | 2022 | |
| Intuitive Surgical, INC. | $110.95 | 2020-2022 | |
| Ethicon US, LLC | $68.47 | 2021-2023 | Ethicon, Stratafix |
| Merck Sharp & Dohme LLC | $19.74 | 2025 | Bridion |
| Conmed Corporation | $16.44 | 2023 | Airseal |
| Integra Lifesciences Corporation | $14.74 | 2023 | Durasorb Monofilament Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Doerhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.